TrueWealth LLC’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-396
Closed -$39K 776
2019
Q3
$39K Hold
396
0.02% 290
2019
Q2
$37K Hold
396
0.02% 303
2019
Q1
$37K Sell
396
-200
-34% -$17.5K 0.02% 295
2018
Q4
$38K Sell
596
-20
-3% -$1.48K 0.02% 287
2018
Q3
$55K Sell
616
-10
-2% -$884 0.03% 260
2018
Q2
$50K Sell
626
-47
-7% -$3.9K 0.02% 267
2018
Q1
$60K Sell
673
-506
-43% -$48.6K 0.03% 241
2017
Q4
$123K Buy
+1,179
New +$133K 0.06% 188

Other funds holding CELG

TrueWealth LLC's CELG Position: Q4 2019 in Review

TrueWealth LLC sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 396 shares — an estimated $39K sold.

TrueWealth LLC first reported a position in CELG in Q4 2017 and held it in 8 quarters. The position peaked at $123K in Q4 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • TrueWealth LLC reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • TrueWealth LLC sold 396 Celgene Corp shares in Q4 2019, an estimated $39K.
  • TrueWealth LLC first reported a position in Celgene Corp in Q4 2017 and held it in 8 quarters.
  • TrueWealth LLC's Celgene Corp position peaked at $123K in Q4 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on TrueWealth LLC's 13F filing for Q4 2019, filed 22 Jan 2020.